Monte Rosa Therapeutics I... (GLUE)
NASDAQ: GLUE
· Real-Time Price · USD
4.25
0.16 (3.91%)
At close: May 12, 2025, 3:59 PM
3.95
-7.06%
Pre-market: May 13, 2025, 04:01 AM EDT
Monte Rosa Therapeutics Revenue
Monte Rosa Therapeutics reported an annual revenue of $75.62M, reflecting a 0% growth. For the quarter ending December 31, 2024, Monte Rosa Therapeutics generated $60.65M in revenue.
Revenue (ttm)
$75.62M
Revenue Growth
0%
Price / Sales Ratio
6.78
Revenue / Employee
$532.55K
Employees
142
Market Cap
261.42M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|